alexa Scholarly-open-access-molecular-docking-journals|OMICS International|Drug Designing: Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Scholarly Open Access Molecular Docking Journals

Drug Designing Open Access is a scholarly journal that provides readers articles without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. Advantages and disadvantages of open-access journals are the subjects of much discussion amongst scholars and publishers. Reactions of existing publishers to Drug Designing Open Access journal publishing have ranged from moving with enthusiasm to a new open-access business model, to experiments with providing as much free or open access as possible, to active lobbying against open-access proposals. A few obvious advantages of Drug Designing Open Access journals include the free access to scientific papers regardless of affiliation with a subscribing library, lower costs for research in academia and industry, in addition to improved access for the general public and higher citation rates for the author. Drug Designing Open Access is a journal dedicated to producing analysis, insight and data relating to questions of importance in understanding the bioinformatics, homology modeling and molecular docking.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on June, 2014

Top